Characteristic | Research cohort database of patients initiated on ART between April 2004 and April 2005 (n = 559) | Routine clinic database of patients initiated on ART between April 2004 and April 2005 (n = 1233) | Routine clinic database of all patients initiated on ART between January 2000 and December 2007 (n = 6421) | P value a |
---|---|---|---|---|
Female, n (%) | 386 (64%) | 765 (62%) | 4112 (64%) | 0.417 |
Age in years, median (IQR) | 38 (33, 44) | 37 (32, 43) | 36 (31, 42) | 0.064 |
WHO stage III & IV, n (%) | 496 (89%) | 975 (79%) | 4581 (71%) | <0.0001 |
CD4 cells/mm3, median (IQR) | 98 (21, 163) | 95 (25, 168) | 121 (147, 187) | 0.232 |
ART regimen, n (%) | Â | Â | Â | Â |
d4T+3TC+nevirapine | 414 (74%) | 727 (59%) | 4224 (66%) | <0.0001 |
ZDV+3TC+efavirenz | 145 (26%) | 506 (41%) | 2117 (34%) | Â |